BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24423610)

  • 21. Low mitochondrial DNA copy number induces chemotherapy resistance via epithelial-mesenchymal transition by DNA methylation in esophageal squamous cancer cells.
    Kubo Y; Tanaka K; Masuike Y; Takahashi T; Yamashita K; Makino T; Saito T; Yamamoto K; Tsujimoto T; Harino T; Kurokawa Y; Yamasaki M; Nakajima K; Eguchi H; Doki Y
    J Transl Med; 2022 Aug; 20(1):383. PubMed ID: 36038893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypomethylation of Alu repetitive elements in esophageal mucosa, and its potential contribution to the epigenetic field for cancerization.
    Matsuda Y; Yamashita S; Lee YC; Niwa T; Yoshida T; Gyobu K; Igaki H; Kushima R; Lee S; Wu MS; Osugi H; Suehiro S; Ushijima T
    Cancer Causes Control; 2012 Jun; 23(6):865-73. PubMed ID: 22527164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6.
    Wei L; Wang B; Hu L; Xu Y; Li Z; Shen Y; Huang H
    Aging (Albany NY); 2020 Nov; 12(21):21091-21113. PubMed ID: 33188661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Landscape of copy number aberrations in esophageal squamous cell carcinoma from a high endemic region of South Africa.
    Brown J; Stepien AJ; Willem P
    BMC Cancer; 2020 Apr; 20(1):281. PubMed ID: 32252688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copy number loss of variation_91720 in PIK3CA predicts risk of esophageal squamous cell carcinoma.
    Wu Y; Liu X; Hu L; Tao H; Guan X; Zhang K; Bai Y; Yang K
    Int J Clin Exp Pathol; 2015; 8(11):14479-85. PubMed ID: 26823766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
    Li P; Liu X; Dong ZM; Ling ZQ
    Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
    Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Morita M; Nakao M; Baba H
    Ann Surg Oncol; 2014 Apr; 21(4):1166-74. PubMed ID: 24318096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma.
    Guo W; Zhang M; Shen S; Guo Y; Kuang G; Yang Z; Dong Z
    Cancer; 2014 Aug; 120(16):2412-23. PubMed ID: 24798237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell Carcinoma.
    Wang Q; Bai J; Abliz A; Liu Y; Gong K; Li J; Shi W; Pan Y; Liu F; Lai S; Yang H; Lu C; Zhang L; Chen W; Xu R; Cai H; Ke Y; Zeng C
    Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):258-70. PubMed ID: 26386145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ABCC4 copy number variation is associated with susceptibility to esophageal squamous cell carcinoma.
    Sun Y; Shi N; Lu H; Zhang J; Ma Y; Qiao Y; Mao Y; Jia K; Han L; Liu F; Li H; Lin Z; Li X; Zhao X
    Carcinogenesis; 2014 Sep; 35(9):1941-50. PubMed ID: 24510239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
    Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of LINE-1 hypomethylation in oropharyngeal squamous cell carcinoma.
    Furlan C; Polesel J; Barzan L; Franchin G; Sulfaro S; Romeo S; Colizzi F; Rizzo A; Baggio V; Giacomarra V; Dei Tos AP; Boscolo-Rizzo P; Vaccher E; Dolcetti R; Sigalotti L; Fratta E
    Clin Epigenetics; 2017; 9():58. PubMed ID: 28572862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer.
    Kalikawe R; Baba Y; Nomoto D; Okadome K; Miyake K; Eto K; Hiyoshi Y; Nagai Y; Iwatsuki M; Ishimoto T; Iwagami S; Miyamoto Y; Yoshida N; Watanabe M; Baba H
    Cancer Sci; 2019 Dec; 110(12):3727-3737. PubMed ID: 31599475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase D1 mRNA level may predict cancer-specific survival in heavy smokers with esophageal squamous cell cancers.
    Xie X; Zhang SS; Wen J; Yang H; Luo KJ; Yang F; Hu Y; Fu JH
    Dis Esophagus; 2014; 27(2):188-95. PubMed ID: 23621299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification and overexpression of
    Hu X; Moon JW; Li S; Xu W; Wang X; Liu Y; Lee JY
    Int J Med Sci; 2016; 13(11):868-874. PubMed ID: 27877079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-DRB1 and HLA-DQB1 methylation changes promote the occurrence and progression of Kazakh ESCC.
    Hu JM; Li L; Chen YZ; Liu C; Cui X; Yin L; Yang L; Zou H; Pang L; Zhao J; Qi Y; Cao Y; Jiang J; Liang W; Li F
    Epigenetics; 2014 Oct; 9(10):1366-73. PubMed ID: 25437052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of microRNA‑449a‑5p promotes esophageal squamous cell carcinoma cell proliferation via cyclin D1 regulation.
    Jiang T; Liu J; Mu J
    Mol Med Rep; 2018 Jul; 18(1):848-854. PubMed ID: 29845226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
    Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y
    Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early G₁ cyclin-dependent kinases as prognostic markers and potential therapeutic targets in esophageal adenocarcinoma.
    Ismail A; Bandla S; Reveiller M; Toia L; Zhou Z; Gooding WE; Kalatskaya I; Stein L; D'Souza M; Litle VR; Peters JH; Pennathur A; Luketich JD; Godfrey TE
    Clin Cancer Res; 2011 Jul; 17(13):4513-22. PubMed ID: 21593195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NGALR is overexpressed and regulated by hypomethylation in esophageal squamous cell carcinoma.
    Cui L; Xu LY; Shen ZY; Tao Q; Gao SY; Lv Z; Du ZP; Fang WK; Li EM
    Clin Cancer Res; 2008 Dec; 14(23):7674-81. PubMed ID: 19047093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.